Literature DB >> 19887910

Prion neurodegeneration: starts and stops at the synapse.

Giovanna R Mallucci1.   

Abstract

Synaptic dysfunction is a key process in the evolution of many neurodegenerative diseases, with synaptic loss preceding that of neuronal cell bodies. In Alzheimer, Huntington, and prion diseases early synaptic changes correlate with cognitive and motor decline, and altered synaptic function may also underlie deficits in a number of psychiatric and neurodevelopmental conditions. The formation, remodelling and elimination of spines and synapses are continual physiological processes, moulding cortical architecture, underpinning the abilities to learn and remember. In disease, however, particularly in protein misfolding neurodegenerative disorders, lost synapses are not replaced and this loss is followed by neuronal death. These two processes are separately regulated, with mechanistic, spatial and temporal segregation of the death 'routines' of synapses and cell bodies. Recent insights into the reversibility of synaptic dysfunction in a mouse model of prion disease at neurophysiological, behavioral and morphological levels call for a deeper analysis of the mechanisms underlying neurotoxicity at the synapse, and have important implications for therapy of prion and other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887910      PMCID: PMC2807691          DOI: 10.4161/pri.3.4.9981

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  32 in total

1.  Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie.

Authors:  E Jamieson; M Jeffrey; J W Ironside; J R Fraser
Journal:  Neuroreport       Date:  2001-07-20       Impact factor: 1.837

2.  Early behavioural changes in scrapie-affected mice and the influence of dapsone.

Authors:  K Guenther; R M Deacon; V H Perry; J N Rawlins
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

3.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

4.  Burrowing into prion disease.

Authors:  R M Deacon; J M Raley; V H Perry; J N Rawlins
Journal:  Neuroreport       Date:  2001-07-03       Impact factor: 1.837

5.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

6.  Impaired recognition memory in rats after damage to the hippocampus.

Authors:  R E Clark; S M Zola; L R Squire
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

7.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

Authors:  J Näslund; V Haroutunian; R Mohs; K L Davis; P Davies; P Greengard; J D Buxbaum
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

8.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

9.  Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

Authors:  Mathew Blurton-Jones; Masashi Kitazawa; Hilda Martinez-Coria; Nicholas A Castello; Franz-Josef Müller; Jeanne F Loring; Tritia R Yamasaki; Wayne W Poon; Kim N Green; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

10.  Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration.

Authors:  G R Mallucci; S Ratté; E A Asante; J Linehan; I Gowland; J G R Jefferys; J Collinge
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

View more
  30 in total

1.  Neuroimmunoendocrine regulation of the prion protein in neutrophils.

Authors:  Rafael M Mariante; Alberto Nóbrega; Rodrigo A P Martins; Rômulo B Areal; Maria Bellio; Rafael Linden
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

Review 2.  Prion neurotoxicity.

Authors:  Nhat T T Le; Bei Wu; David A Harris
Journal:  Brain Pathol       Date:  2019-01-17       Impact factor: 6.508

Review 3.  Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Curr Opin Cell Biol       Date:  2011-02-02       Impact factor: 8.382

Review 4.  The intricate mechanisms of neurodegeneration in prion diseases.

Authors:  Claudio Soto; Nikunj Satani
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

5.  Identification of Anti-prion Compounds using a Novel Cellular Assay.

Authors:  Thibaut Imberdis; James T Heeres; Han Yueh; Cheng Fang; Jessie Zhen; Celeste B Rich; Marcie Glicksman; Aaron B Beeler; David A Harris
Journal:  J Biol Chem       Date:  2016-11-01       Impact factor: 5.157

6.  Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.

Authors:  Susan F Godsave; Holger Wille; Jason Pierson; Stanley B Prusiner; Peter J Peters
Journal:  Neurobiol Aging       Date:  2013-06       Impact factor: 4.673

Review 7.  RNA binding proteins: a common denominator of neuronal function and dysfunction.

Authors:  Epaminondas Doxakis
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

Review 8.  A central role for calcineurin in protein misfolding neurodegenerative diseases.

Authors:  Syed Zahid Ali Shah; Tariq Hussain; Deming Zhao; Lifeng Yang
Journal:  Cell Mol Life Sci       Date:  2016-09-28       Impact factor: 9.261

Review 9.  Identification of anti-prion drugs and targets using toxicity-based assays.

Authors:  Robert Cc Mercer; David A Harris
Journal:  Curr Opin Pharmacol       Date:  2019-01-23       Impact factor: 5.547

10.  SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury.

Authors:  Andrew D Sauerbeck; Mihika Gangolli; Sydney J Reitz; Maverick H Salyards; Samuel H Kim; Christopher Hemingway; Maud Gratuze; Tejaswi Makkapati; Martin Kerschensteiner; David M Holtzman; David L Brody; Terrance T Kummer
Journal:  Neuron       Date:  2020-05-08       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.